Joseph C Cappelleri Selected Research

bazedoxifene

10/2016	Most bothersome symptom in women with genitourinary syndrome of menopause as a moderator of treatment effects.
6/2014	Bazedoxifene versus oral bisphosphonates for the prevention of nonvertebral fractures in postmenopausal women with osteoporosis at higher risk of fracture: a network meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph C Cappelleri Research Topics

Disease

32	Pain (Aches) 04/2024 - 06/2009
17	Erectile Dysfunction 04/2018 - 05/2003
16	Neoplasms (Cancer) 10/2023 - 01/2008
14	Atopic Dermatitis (Atopic Eczema) 12/2024 - 04/2019
14	Osteoarthritis 04/2024 - 01/2011
14	Ulcerative Colitis 04/2023 - 02/2015
14	Psoriatic Arthritis 10/2022 - 11/2018
13	Fatigue 08/2023 - 06/2014
13	Fibromyalgia (Fibrositis) 01/2018 - 06/2009
11	Chronic Disease (Chronic Diseases) 08/2023 - 01/2013
10	Renal Cell Carcinoma (Grawitz Tumor) 06/2019 - 01/2008
8	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2022 - 02/2015
8	Pruritus (Itching) 10/2021 - 02/2015
6	Infections 02/2024 - 01/2019
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2022 - 02/2019
5	Ankylosing Spondylitis 08/2023 - 01/2019
5	Peripheral Nervous System Diseases (PNS Diseases) 04/2015 - 03/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 08/2019
4	Necrosis 04/2022 - 12/2012
4	Neuralgia (Stump Neuralgia) 01/2021 - 03/2011
3	Breast Neoplasms (Breast Cancer) 12/2023 - 11/2020
3	COVID-19 09/2023 - 12/2022
3	Rheumatoid Arthritis 01/2022 - 01/2011
3	Atrial Fibrillation 01/2022 - 01/2021
3	Hemorrhage 01/2022 - 10/2018
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 01/2019
3	Arthritis (Polyarthritis) 01/2021 - 01/2011
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 11/2016
3	Disease Progression 01/2021 - 01/2008
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 01/2018
3	Anxiety Disorders (Anxiety Disorder) 03/2012 - 10/2008
2	Post-Acute COVID-19 Syndrome 02/2024 - 01/2023
2	Inflammation (Inflammations) 08/2023 - 10/2022
2	Back Pain (Backache) 08/2023 - 01/2022
2	Eczema 10/2021 - 06/2021
2	Leukemia 06/2020 - 06/2019
2	Ovarian Neoplasms (Ovarian Cancer) 05/2020 - 01/2018
2	Chronic Pain 05/2017 - 01/2017
2	Postmenopausal Osteoporosis 10/2016 - 06/2014
2	Contracture 03/2012 - 11/2011
2	Dupuytren Contracture (Dupuytrens Contracture) 11/2011 - 10/2011
2	Kidney Neoplasms (Kidney Cancer) 09/2011 - 06/2009
2	Sleep Initiation and Maintenance Disorders (Insomnia) 06/2009 - 04/2008

Drug/Important Bio-Agent (IBA)

30	tofacitinibIBA 08/2023 - 02/2015
18	Pregabalin (Lyrica)FDA Link 01/2021 - 06/2009
17	Sildenafil Citrate (Viagra)FDA Link 04/2018 - 05/2003
14	Janus Kinase InhibitorsIBA 12/2024 - 02/2015
10	Opioid Analgesics (Opioids)IBA 04/2023 - 01/2014
9	Duloxetine Hydrochloride (Cymbalta)FDA Link 04/2015 - 11/2011
8	crisaboroleIBA 01/2022 - 07/2019
7	Ointments (Pastes)IBA 01/2022 - 07/2019
6	Adalimumab (Humira)FDA Link 08/2022 - 01/2019
6	Sunitinib (Sutent)FDA Link 06/2019 - 08/2008
5	Prostaglandins AIBA 08/2022 - 02/2015
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 01/2013
4	Phosphodiesterase 4 InhibitorsIBA 12/2024 - 07/2019
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2018
4	Tyrosine Kinase InhibitorsIBA 12/2020 - 01/2019
4	Axitinib (AG 013736)IBA 12/2018 - 01/2008
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2024 - 04/2022
3	tanezumabIBA 04/2024 - 01/2022
3	BNT162 VaccineIBA 02/2024 - 12/2022
3	palbociclibIBA 12/2023 - 11/2020
3	abrocitinibIBA 08/2023 - 09/2021
3	Janus KinasesIBA 08/2023 - 01/2018
3	vedolizumabIBA 04/2022 - 09/2019
3	AnticoagulantsIBA 01/2022 - 01/2021
3	Gemtuzumab (Mylotarg)FDA Link 08/2021 - 02/2019
3	bosutinibIBA 01/2021 - 01/2019
3	Celecoxib (Celebrex)FDA Link 01/2020 - 01/2011
3	Antirheumatic Agents (DMARD)IBA 01/2020 - 04/2016
3	Inotuzumab OzogamicinIBA 01/2020 - 01/2018
3	Amitriptyline (Elavil)FDA LinkGeneric 02/2014 - 11/2011
3	Interferon-alpha (Interferon Alfa)IBA 06/2009 - 08/2008
3	Insulin (Novolin)FDA Link 01/2008 - 04/2002
2	Calcineurin InhibitorsIBA 12/2024 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 10/2023 - 12/2020
2	Hormones (Hormone)IBA 10/2023 - 11/2020
2	avelumabIBA 10/2023 - 01/2023
2	Indicators and Reagents (Reagents)IBA 09/2023 - 09/2011
2	C-Reactive ProteinIBA 08/2023 - 10/2022
2	golimumab FDA Link 01/2021 - 09/2019
2	Dasatinib (BMS 354825)FDA Link 01/2021 - 01/2019
2	Infliximab (Remicade)FDA Link 01/2021 - 09/2019
2	nilotinib FDA Link 01/2021 - 01/2019
2	glasdegibIBA 01/2021 - 10/2020
2	PlatinumIBA 05/2020 - 01/2018
2	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 09/2019
2	blinatumomabIBA 01/2020 - 01/2019
2	Analgesics (Analgesic Drugs)IBA 01/2019 - 06/2009
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018 - 01/2008
2	bazedoxifeneIBA 10/2016 - 06/2014
2	Bupropion (Wellbutrin)FDA LinkGeneric 04/2012 - 04/2008
2	Varenicline (Chantix)FDA Link 04/2012 - 04/2008

Therapy/Procedure

49	Therapeutics 10/2023 - 11/2006
8	Drug Therapy (Chemotherapy) 05/2022 - 01/2012
3	Aftercare (After-Treatment) 10/2020 - 06/2010
2	Length of Stay 10/2018 - 10/2011
2	Patient Readmission 02/2017 - 10/2011
2	Injections 11/2011 - 04/2002